Don’t let the cost of the Neupro patch disrupt your Parkinson’s or restless legs treatment. The UCB Patient Assistance Program provides Neupro free of charge to eligible patients — with income limits recently broadened to 500% of the poverty level — and we manage your entire enrollment for a flat $69.95 per month.
The Neupro Patient Assistance Program is run by UCB, the patch’s manufacturer, with patient support through ucbCARES, and provides Neupro at no medication cost to qualifying patients. Its eligibility is among the broadest in neurology: household income up to 500% of the Federal Poverty Level qualifies — a ceiling UCB recently raised from 300% — and the program serves the uninsured, the underinsured, and insured patients with significant financial hardship who have exhausted their coverage options. Applying directly (1-877-785-8906; general support 1-844-599-2273) is always free. The harder parts are what surround the application: income documentation, neurologist coordination, hardship documentation for insured applicants, prior-authorization records, and annual renewals — plus the practical reality that Parkinson’s patients often manage several medications at once, each with its own program. For a flat $69.95 per month, our Patient Advocates handle every step, across every medication you take.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$950 | Save ~$880/mo |
| CVS Pharmacy | ~$1,000 | Save ~$930/mo |
| Walmart | ~$750 | Save ~$680/mo |
| Costco | ~$720 | Save ~$650/mo |
Generic pramipexole | ~$10 | Already low (oral alt) |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The UCB Patient Assistance Program is free to apply for and provides Neupro at no medication cost if approved. Our $69.95/month service covers full advocacy — for patients and caregivers who want an experienced team managing enrollment end-to-end, especially across the multi-drug regimens Parkinson’s care usually involves.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Neupro:
Still $700–$1,000 per month even with the best discount
UCB reviews eligibility based on insurance status, income, and financial hardship. You will generally qualify if the following are true — and if your situation doesn’t fit neatly, contact AffordMyPrescriptions so we can review your case and determine if you qualify for Neupro assistance:
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Neupro (rotigotine) is a dopamine agonist delivered through a once-daily transdermal patch — the only Parkinson’s and restless legs treatment that maintains continuous 24-hour drug levels through the skin rather than in peaks and troughs from pills.
How Neupro Works:
Parkinson’s symptoms arise from the loss of dopamine-producing neurons; restless legs syndrome also involves dopamine signaling. Rotigotine stimulates dopamine receptors directly, standing in for the missing neurotransmitter. The patch format is the clinical point: continuous delivery avoids the wearing-off swings of oral dosing, keeps working overnight (when RLS symptoms peak and Parkinson’s early-morning stiffness sets in), and bypasses swallowing — which matters enormously in later-stage Parkinson’s, when pills become difficult and hospital stays interrupt oral regimens.
Form and Use:
One patch applied daily to clean, dry skin (abdomen, thigh, hip, flank, shoulder, or upper arm), rotating sites so the same spot isn’t reused within 14 days. Strengths run 1–8 mg/24 hours, titrated weekly to effect. Two practical notes with cost implications: patches must be stored properly and replaced daily — there’s no stretching a supply — and the patch contains aluminum, so it must be removed before MRI scans. A torn or lost patch is a lost day of therapy, one more reason the 30-day supply math needs a program behind it.
Generic Availability:
There is no generic rotigotine patch in the U.S. — none approved, none marketed — with drug-product patents running to 2030 and beyond. Transdermal formulations are notoriously hard to copy, so early generic entry is unlikely. Oral dopamine agonists (ropinirole, pramipexole) are cheap generics, but they are different drugs in a different format — an option to discuss with your neurologist, not a pharmacy substitution. For the patch itself, UCB’s programs are the affordability route for years to come.
Warnings:
Neupro can cause sudden sleep onset — including falling asleep during daily activities without warning — and patients should not drive until they know how it affects them. Dopamine agonists can trigger impulse-control changes (compulsive gambling, shopping, eating, or sexual behavior) that patients and families should watch for and report; they are reversible with dose changes. Other cautions: orthostatic hypotension, hallucinations in Parkinson’s patients, application-site reactions (rotate sites), and the sulfite content for allergic patients. Never stop abruptly — tapering prevents withdrawal symptoms.
UCB’s list price is $806.59 per month — about $9,700 per year. Patients with household income up to 500% of the Federal Poverty Level can receive Neupro free through the UCB Patient Assistance Program; our $69.95 monthly fee covers full advocacy and enrollment management.
Yes — UCB’s current application sets the ceiling at 500% of the Federal Poverty Level, up from the 300% on older forms still circulating online. That’s roughly $79,800 for a one-person household. Many patients who were denied under the old limit — or never applied because they assumed they earned too much — now qualify. If that’s you, it’s worth reapplying.
Yes — under Part D. UCB’s own data show about 68% of Part D patients pay $100 or less per month, Extra Help enrollees pay around $4–$10 per fill, and the $2,100 annual out-of-pocket cap (2026) limits everyone’s total drug spending. Insured Medicare patients facing genuine hardship can also apply to the UCB PAP — we document those cases properly.
? No — the $10-per-month card (up to $1,500 per year) is commercial-insurance only. Medicare patients rely on the Part D cap, Extra Help if income-qualified, or the PAP.
No — no generic rotigotine patch is approved or marketed in the U.S., with patents running to 2030 and beyond. Generic oral dopamine agonists exist but are different drugs in pill form — a clinical conversation for your neurologist, not a counter swap.
Continuous 24-hour delivery — no wearing-off between doses, coverage through the night when RLS peaks and morning stiffness sets in, and no swallowing required. For patients with swallowing difficulty or those unable to take oral meds around surgery, the patch is sometimes the only practical option — which makes keeping it affordable a genuine continuity-of-care issue.
If struggling with Neupro cost, we can help — or guide you to generic oral pramipexole or ropinirole. Check eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.